Perfuze, a Galway, Ireland-based medical device company, raised €22M in additional funding.
The round was led by existing investors including Earlybird, EQT Life Sciences, Seroba and SV Health.
Led by CEO Wayne Allen, Perfuze is a medical device company dedicated to developing new catheter-based aspiration technology for the treatment of acute ischemic stroke. Its proprietary platform is designed to optimize clot removal efficiency, enhance procedural simplicity, and improve clinical outcomes.
The company intends to use the funds to support the Limited Market Release of the Zipline™ and Millipede™ catheters while advancing ongoing clinical and R&D initiatives to further enhance stroke treatment capabilities.
FinSMEs
13/03/2025